A majority upheld part of the process used to create the package, but a Mercer analyst says there's more to the story.

Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

Ruth Link-Gelles, PhD, MPH, of the CDC's National Center for Immunization and Respiratory Diseases, who has been leading the ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Brewer was terminated by Health and Human Services Sec. Robert F. Kennedy Jr. from the vaccine advisory panel in June.

Several northeastern states, including Maine, New York, Rhode Island and Connecticut, are considering forming the group to ...

In a matter of weeks, the credibility of the U.S. vaccine advisory panel has been upended after Kennedy removed all 17 of its ...

Legislative changes in states like Maine and Colorado aim to protect vaccine access and adapt to federal policy shifts ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

The group cast aside evidence-based science in favor of anti-vaccine propaganda and dangerous falsehoods that will hurt ...

Dear ACIP Secretariat, The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...